April 8, 2025: MDL Against Ozempic and Other GLP-1s Top 1,600 in April As of April 1, 2025, there are 1,685 active lawsuits pending against Novo Nordisk and other pharmaceutical companies that sold GLP-1 drugs like Ozempic
The weighted median provides a consistent estimate of the causal effect even when up to 50% of the information comes from genetic variants that are invalid instruments [43]
And for many, they delivered: 10%, 15%, or even 20% body weight lost Lower glucose, blood pressure, and inflammation Fewer heart attacks, as seen in the SELECT trial It felt like medicine had cracked the metabolic code
This could be due to an allergic reaction to NAC or one of its constituents
A nuclear glutathione cycle within the cell cycle
(PubMed) Sano M, Bell K, Cote L, et al